Russia’s aggression has caused a dramatic change for traders and investors in markets across all asset classes.
As the US central bank prepares to address the highest inflation levels in four decades, the prospects for higher US interest rates have pushed the dollar to higher lows and higher highs against other world fiat currencies.
The emergence of a worrisome coronavirus variant is benefiting shares of vaccine makers Moderna Inc (MRNA), BioNTech (BNTX) and Pfizer (PFE) as investors search for winning bets in markets roiled by uncertainty in recent days.
Moderna shares have jumped 28% since last week when the variant, named Omicron, triggered global alarm. Shares of vaccine partners Pfizer and BioNtech have also climbed over that time, with Pfizer up 6% and U.S. shares of BioNTech jumping 15%, in contrast to a decline in the S&P 500 of 2.5%.
On the day after the Thanksgiving holiday in the US, news that another COVID-19 variant is emerging from South Africa roiled markets across all asset classes.
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
